Legal & General Group
ANRO icon

Legal & General Group’s Alto Neuroscience ANRO Stock Holding History

Legal & General Group’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,135
Closed -$4.61K – 3562
2025
Q1 		$4.61K Hold
2,135
– – ﹤0.01% 3287
2024
Q4 		$9.03K Hold
2,135
– – ﹤0.01% 3268
2024
Q3 		$24.4K Buy
2,135
+1,241
+139% +$15.2K ﹤0.01% 2970
2024
Q2 		$9.56K Buy
+894
New +$11.6K ﹤0.01% 3305

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Legal & General Group's ANRO Position: Q2 2025 in Review

Legal & General Group sold out of Alto Neuroscience (ANRO) in Q2 2025, closing a stake of 2,135 shares — an estimated $4.61K sold.

Legal & General Group first reported a position in ANRO in Q2 2024 and held it in 4 quarters. The position peaked at $24.4K in Q3 2024. 80 funds tracked by Wall St. Rank hold ANRO as of Q2 2025.

  • Legal & General Group reported no remaining Alto Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 2,135 Alto Neuroscience shares in Q2 2025, an estimated $4.61K.
  • Legal & General Group first reported a position in Alto Neuroscience in Q2 2024 and held it in 4 quarters.
  • Legal & General Group's Alto Neuroscience position peaked at $24.4K in Q3 2024.
  • 80 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.